| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $4.93B | +0.1% |
| Cost of Revenue | $2.75B | -1.6% |
| Gross Profit | $2.18B | +2.4% |
| R&D Expense | $30.8M | +0.7% |
| SG&A Expense | $1.09B | +2.7% |
| Operating Income | $634.2M | +4.4% |
| Pre-tax Income | $504.3M | +6.4% |
| Income Tax | $118.6M | +14.7% |
| Net Income | $384.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $404.5M | -6.2% |
| Inventory | $447.0M | -7.5% |
| Current Assets | $1.07B | -3.4% |
| Total Assets | $5.98B | +31.3% |
| Current Liabilities | $960.3M | +5.7% |
| Long-term Debt | $3.76B | +50.1% |
| Total Liabilities | $5.41B | +28.2% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Capital Expenditures | $97.3M | -47.5% |
| Investing Cash Flow | -$96.7M | +48.5% |
| Financing Cash Flow | $1.08B | +380.4% |
| +4.4% |
| EPS (Basic) | $2.21 | +3.3% |
| EPS (Diluted) | $2.16 | +3.8% |
| Stockholders' Equity |
| $559.0M |
| +72.9% |